---
figid: PMC7859451__fendo-11-612396-g005
figlink: pmc/articles/PMC7859451/figure/f5/
number: F5
caption: The identified signaling pathways involved in the mediation of sensitivity/resistance
  versus endocrine therapy. The signaling pathways that involve cyclin D—cyclin-dependent
  kinase 4 and 6 (CDK4/6)/6-INK4- retinoblastoma (Rb) and phosphatidylinositol-3 kinase/mechanistic
  target of rapamycin (PI3K/mTOR) play a central role in cell cycle progression, cellular
  differentiation, growth, survival and metabolism. Dysregulation of these pathways
  results in genetic/epigenetic alterations, increased proliferation and evasion of
  apoptosis, as observed in hormone receptor-positive breast cancer (HR)+, and have
  been involved in the development of endocrine therapy resistance. PI3K/mTOR pathway
  activates S6 kinase and leads to estrogen receptor (ER) signaling activation. Activation
  of ER pathway upregulates the protein expression of cyclin D, activates cyclin D—CDK4/6/6-INK4-
  Rb pathway and increases cell cycle progression (A). The resistance to PI3K/mTOR
  pathway inhibitors occurs via an aberrant activation of RAS/RAF/MEK/ERK pathway
  that produces an additional assembly of cyclin D-CDK4/6 complexes (B). In HR+ breast
  cancer the cyclin D - CDK4/6/6-INK4- Rb pathway, in particular cyclin D and CDK4,
  is overexpressed. Activation of PI3K/mTOR pathway leads to cyclin D upregulation,
  binding and activation of CDK2 (if CDK4/6 is absent) and consecutive Rb phosphorylation
  and cell cycle progression. CDK4/6 inhibitors have synergistic effects to endocrine
  therapy (C).
pmcid: PMC7859451
papertitle: 'Natural Compounds in Sex Hormone-Dependent Cancers: The Role of Triterpenes
  as Therapeutic Agents.'
reftext: Codruţa Şoica, et al. Front Endocrinol (Lausanne). 2020;11:612396.
pmc_ranked_result_index: '450'
pathway_score: 0.8872948
filename: fendo-11-612396-g005.jpg
figtitle: Identified signaling pathways involved in the mediation of sensitivity/resistance
  versus endocrine therapy
year: '2020'
organisms:
- Mus musculus
- Rattus norvegicus
- Hibiscus syriacus
- Monteverdia robusta
- Siphonodon celastrineus
- Mouse mammary tumor virus
- Lipschitzia divaricata
- Ganoderma lingzhi
- Schisandra glaucescens
- Amphipterygium adstringens
- Carissa carandas
- Alisma plantago-aquatica
- Walsura chrysogyne
- Cnidoscolus spinosus
- Davidia involucrata
- Chuquiraga erinacea
- Anemone flaccida
- Lysimachia nummularia
- Rhododendron arboreum
- Gynostemma pentaphyllum
- Gypsophila oldhamiana
- Picrasma quassioides
- Lysimachia ciliata
- Betula utilis
- Saussurea graminea
- Alisma plantago-aquatica subsp. orientale
- Androsace umbellata
- Cussonia bancoensis
- Malus pumila
- Vitellaria paradoxa
- Mukdenia rossii
- Clematis ganpiniana
- Persea americana
- Ficus carica
- Betula pendula
- Ibervillea sonorae
- Sandoricum koetjape
- Cucumis sativus
- Momordica charantia
- Trichosanthes kirilowii
- Malus domestica
- Bolbostemma paniculatum
- Panax ginseng
- Nematostylis anthophylla
- Camellia sinensis
- Hemsleya pengxianensis
- Hemsleya amabilis
- Tripterygium wilfordii
- Garcinia celebica
- Centella asiatica
- Trichosanthes cucumerina
- Megacodon stylophorus
- Crataegus pinnatifida
- Bupleurum chinense
- Euphorbia sieboldiana
- Ganoderma lucidum
- Eclipta prostrata
- Actaea cimicifuga
- Actaea racemosa
- Actaea yunnanensis
- Potentilla discolor
- Gleditsia sinensis
- Ficus microcarpa
- Ficus religiosa
- Cassipourea lanceolata
- Securidaca longipedunculata
- Abies veitchii
- Cleome khorassanica
- Scyphiphora hydrophyllacea
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7859451__fendo-11-612396-g005.html
  '@type': Dataset
  description: The identified signaling pathways involved in the mediation of sensitivity/resistance
    versus endocrine therapy. The signaling pathways that involve cyclin D—cyclin-dependent
    kinase 4 and 6 (CDK4/6)/6-INK4- retinoblastoma (Rb) and phosphatidylinositol-3
    kinase/mechanistic target of rapamycin (PI3K/mTOR) play a central role in cell
    cycle progression, cellular differentiation, growth, survival and metabolism.
    Dysregulation of these pathways results in genetic/epigenetic alterations, increased
    proliferation and evasion of apoptosis, as observed in hormone receptor-positive
    breast cancer (HR)+, and have been involved in the development of endocrine therapy
    resistance. PI3K/mTOR pathway activates S6 kinase and leads to estrogen receptor
    (ER) signaling activation. Activation of ER pathway upregulates the protein expression
    of cyclin D, activates cyclin D—CDK4/6/6-INK4- Rb pathway and increases cell cycle
    progression (A). The resistance to PI3K/mTOR pathway inhibitors occurs via an
    aberrant activation of RAS/RAF/MEK/ERK pathway that produces an additional assembly
    of cyclin D-CDK4/6 complexes (B). In HR+ breast cancer the cyclin D - CDK4/6/6-INK4-
    Rb pathway, in particular cyclin D and CDK4, is overexpressed. Activation of PI3K/mTOR
    pathway leads to cyclin D upregulation, binding and activation of CDK2 (if CDK4/6
    is absent) and consecutive Rb phosphorylation and cell cycle progression. CDK4/6
    inhibitors have synergistic effects to endocrine therapy (C).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLK1
  - PTEN
  - MAP2K1
  - MAP2K2
  - RICTOR
  - RORC
  - PER1
  - AKT2
  - AKT3
  - AKT1
  - FGF1
  - FGF7
  - FGF8
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF23
  - FGF18
  - FGF20
  - FGF22
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF9
  - FGF17
  - FGF16
  - FGF19
  - FGF21
  - C1QB
  - C1R
  - C1QA
  - C1QC
  - C1S
  - Cl
  - cancer
genes:
- word: PIK
  symbol: PLK
  source: hgnc_prev_symbol
  hgnc_symbol: PLK1
  entrez: '5347'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: pia
  symbol: PIA
  source: hgnc_alias_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: TOR
  symbol: TOR
  source: hgnc_alias_symbol
  hgnc_symbol: RORC
  entrez: '6097'
- word: per
  symbol: PER
  source: hgnc_prev_symbol
  hgnc_symbol: PER1
  entrez: '5187'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: TOR
  symbol: TOR
  source: hgnc_alias_symbol
  hgnc_symbol: RORC
  entrez: '6097'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: FGF)
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: Cl
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1QB
  entrez: '713'
- word: Cl
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1R
  entrez: '715'
- word: Cl
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1QA
  entrez: '712'
- word: Cl
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1QC
  entrez: '714'
- word: Cl
  symbol: C1
  source: bioentities_symbol
  hgnc_symbol: C1S
  entrez: '716'
chemicals:
- word: Cl
  source: MESH
  identifier: D002713
diseases:
- word: cancer
  source: MESH
  identifier: D009369
figid_alias: PMC7859451__F5
redirect_from: /figures/PMC7859451__F5
figtype: Figure
---
